Market View Contents 6

6
Contents
Market View: Equities
cautious ahead of ECB
Aer Lingus: Release traffic
stats and announce positive
union vote on IASS
NOVEMBER 2014
Market View
European equities opened lower, despite a record close in the S&P overnight
A worsening European economy and signs Britain’s recovery has stumbled are hardening the
stance of some Bank of England members, who want to keep the benchmark rate at a
record-low 0.5 percent
German Factory orders were lower this morning at 0.8% (survey 2.3%, prior -5.7%)
Economic data will focus on the Bank of England Rates meeting at 12.00 and ECB Rates
meeting at 12.45.
Aer Lingus – (N/C)
Previous Close
€1.69
Following yesterday’s IMS Aer Lingus released October traffic
stats this morning, showing continued growth in its long haul
offering
Short haul was 2.1% lower YoY, however long haul posted
another strong performance, up 29% YoY
Significantly, following the IMS, Aer Lingus also announced that it
had received trade union support on the longstanding pension
issue
Comment: While load factors remained below low cost competitors at
79.6%, the company continues to improve this metric and total passengers
carried was also up 2.3% YoY. The positive trade union ballot announced
yesterday is an important step forward for the company and a resolution of
the pension issue should remove a substantial overhang for the share
price. The proposal must now receive shareholder approval and be put
forward by the Pension trustee for approval by the Pension Authority.
Should this occur it would be more good news for the flag carrier, which
saw operating profit increase 19% to €112.9m in the last quarter. The
company has sufficient free cash flow and cash on deposit to meet the
proposed €191m pension obligation and any resolution would remove a
significant liability on the balance sheet moving forward. The shares are
trading on 13x FY15e earnings against the industry on 10x, however we
would expect the airline to re-rate closer to peers once the pension issue is
resolved.
Siemens – (N/C)
Previous Close
€89.08
Siemens has released earnings this morning largely in line with
consensus
Revenues were up 1% YoY to €20.6bn but slightly below
consensus of €20.68bn
Q4 total sectors profit was €2.195bn, below consensus of €2.4bn
Comments: Results are largely in line for Siemens with net income up to
€1.44bn and EPS of €1.72 for the quarter. The company also confirmed
the sale of its hearing aid unit for €2.2bn. We removed Siemens from the
core portfolio noting geo-political concerns and the impact on-going
sanctions in Russia would have on performance. The company has again
reiterated this concern while discussing the outlook for 2015. Siemens
sees EPS growth of 15% in 2015, however, given that they expect organic
growth to be flat YoY the increase is likely to come from divestures of noncore businesses, like the sale of the hearing aid unit, announced today.
We continue to like the restructuring story of Siemens but remain cautious
given the potential impact of on-going geo-political tensions could have on
earnings. The shares trade on 11.3x FY15e earnings a discount to peers
on 14x.
Siemens: Earnings in line
IRISH PAPERS TODAY
Ikea, Pepsi amongst 340
companies with secret
Luxembourg tax deals
(The Irish Times)
Glanbia has paid over €1bn
into Luxembourg companies
to cut Irish tax bill
(The Irish Independent)
Tone of Trichet letter made it
clear ECB was calling the
shots for Ireland
(The Irish Times)
TH
INTERNATIONAL
PAPERS TODAY
Republicans push for probusiness reform
(Financial Times)
AstraZeneca profits falls
sharply
(Wall Street Journal)
Cameron loses support from
EU allies
(Financial Times)
www.cantorfitzgerald.ie
Equities
Research
Portfolio Management
Bonds
Regulatory Information
This material is approved for distribution in Ireland by Cantor Fitzgerald Ireland Ltd. Cantor Fitzgerald Ireland Ltd (“CFIL”) is regulated by the Central
Bank of Ireland. Cantor Fitzgerald Ireland Ltd is a member firm of the Irish Stock Exchange and the London Stock Exchange.
Where CFIL wishes to make this and other Cantor Fitzgerald research available to Retail clients, such information is provided without liability and in
accordance with our terms and conditions that are available on the CFIL website.
6th JUNE 2012
Buy
Previous Close: €39.84
Price Target: €49.00
No report is intended to and does not constitute a personal recommendations or investment advice nor does it provide the sole basis for any
evaluation of the securities that may be the subject matter of the report. Specifically, the information contained in this report should not be taken as
an offer or solicitation of investment advice, or to encourage the purchased or sale of any particular security. Not all recommendations are
necessarily suitable for all investors and CFIL recommend that specific advice should always be sought prior to investment, based on the particular
circumstances of the investor either from your CFIL investment adviser or another investment adviser.
CFIL takes all responsibility to ensure that reasonable efforts are made to present accurate information but CFIL gives no warranty or guarantee as
to, and do not accept responsibility for, the correctness, completeness, timeliness or accuracy of the information provided or its transmission. This is
entirely at the risk of the recipient of the report. Nor shall CFIL, its subsidiaries, affiliates or parent company or any of their employees, directors or
agents, be liable to for any losses, damages, costs, claims, demands or expenses of any kind whatsoever, whether direct or indirect, suffered or
incurred in consequence of any use of, or reliance upon, the information. Any person acting on the information contained in this report does so
entirely at his or her own risk
All estimates, views and opinions included in this research note constitute CANTOR IRELAND’s judgment as of the date of the note but may be
subject to change without notice. Changes to assumptions may have a material impact on any recommendations made herein.
Unless specifically indicated to the contrary this research note has not been disclosed to the covered issuer(s) in advance of publication.
Past performance is not a reliable guide to future performance. The value of your investment may go down as well as up. Investments denominated
in foreign currencies are subject to fluctuations in exchange rates, which may have an adverse affect on the value of the investments, sale proceeds,
and on dividend or interest income. The income you get from your investment may go down as well as up. Figures quoted are estimates only; they
are not a reliable guide to the future performance of this investment.
Conflicts of Interest & Share Ownership Policy
It is noted that research analysts' compensation is impacted upon by overall firm profitability and accordingly may be affected to some extent by
revenues arising other CANTOR IRELAND business units including Fund Management and Stock broking. Revenues in these business units may
derive in part from the recommendations or views in this report. Notwithstanding, CANTOR IRELAND is satisfied that the objectivity of views and
recommendations contained in this note has not been compromised. Nonetheless CANTOR IRELAND is satisfied that the impartiality of research,
views and recommendations remains assured.
Our conflicts of interest management policy is available at the following link;
http://www.cantorfitzgerald.ie/regulation_mifld.shtml
Analyst Certification
Each research analyst responsible for the content of this research note, in whole or in part, certifies that: (1) all of the views expressed accurately
reflect his or her personal views about those securities or issuers; and (2) no part of his or her compensation was, is, or will be, directly or indirectly,
related to the specific recommendations or views expressed by that research analyst in the research note.
US distribution
This research note is being distributed by (CF Ireland / CF Europe / CF US / CF Canada / CF Hong Kong) in the United States and is intended for
distribution in the United States solely to “major U.S. institutional investors” (as such term is defined in Rule15a-6 of the U.S. Securities Exchange
Act of 1934 and applicable interpretations relating thereto) and is not intended for the use of any person or entity that is not a major institutional
investor. This material is intended solely for institutional investors and investors who Cantor reasonably believes are institutional investors. It is
prohibited for distribution to non-institutional clients including retail clients, private clients and individual investors. Major Institutional Investors
receiving this research note should effect transactions in securities discussed in this research note through Cantor Fitzgerald & Co. This research
note has been prepared in whole or in part by research analysts employed by non-US affiliates of Cantor Fitzgerald & Co that are not registered as
broker-dealers in the United States. These non-US research analysts are not registered as associated persons of Cantor Fitzgerald & Co. and are
not licensed or qualified as research analysts with FINRA or any other US regulatory authority and, accordingly, may not be subject (among other
things) to FINRA’s restrictions regarding communications by a research analyst with a subject company, public appearances by research analysts,
and trading securities held by a research analyst account.
UK distribution
This research note is approved for distribution in the United Kingdom by Cantor Fitzgerald Europe (“CFE”). CFE is authorised and regulated by the
Financial Conduct Authority (“FCA”). While we believe this information and the materials upon which this information was based is accurate, except
for any obligations under the rules of the FCA, we do not guarantee its accuracy. This material is only intended for use by eligible counterparties or
professional clients who fall within articles 19 or 49 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2001 and not the
general investing public. None of the investments or investment services mentioned or described herein are available to other persons in the U.K
and in particular are not available to "retail clients” as defined by the rules of the FCA.
Other important disclosures
Prices quoted in this research note, unless otherwise indicated, are as of close on the previous trading day.
The distribution of this research note in other jurisdictions may be restricted by law and persons into whose possession this specialist sales market
commentary publication comes should inform themselves about and observe any such restrictions. By accepting this research note you agree to be
bound by the foregoing instructions.
Sources: CANTOR IRELAND Research, Bloomberg
Dublin: 75 St. Stephen’s Green, Dublin 2, Ireland. Tel : +353 1 633 3800. Fax : +353 1 633 3856/+353 1 633 3857
CORK: Dolmen House, 45 South Mall, Cork. Tel: +353 21 422 2122.
LIMERICK: Theatre Court, Lower Mallow Street, Limerick. Tel: +353 61 436500.
www.cantorfitzgerald.ie
Email : ireland@cantor.com web : www.cantorfitzgerald.ie
Equities
Research
Portfolio Management
Bonds